In Conversation with… Dr Kathleen McHugh, Consultant Clinical & Health Psychologist, BMT Unit, QEUH, Glasgow

In this vlogcast, Dr Kathleen McHugh shares her talk/presentation – Psychological adjustment after diagnosis of MPN; coping with uncertainty.​ The talk focuses on coping with a serious illness diagnosis, particularly for newly diagnosed patients and their families. ​ Dr McHugh uses analogies and practical advice to help patients understand and manage their emotional responses to…

Invitation to UK based MF patients to take part in an online discussion

Have You Been Diagnosed with Myelofibrosis? Evolve Fieldwork is inviting United Kingdom patients living with Myelofibrosis to participate in a confidential, one-time, 60-minute online discussion. Your experiences will help improve support, information, and care for the Myelofibrosis community. 80 GBP remuneration as a thank-you for your valuable time. Research conducted within ethical guidelines (Market Research…

MPN Voice Research Funding Call

Research Funding – MPN Voice has a mission to encourage research for the benefit of MPN patients and has prior and existing research funding commitments, for example support for MOSAICC and for the Mithridate studies. Funding to support either the entirety or part of specific research projects will be provided through specific research funding calls. …

In Conversation with… Dr Patrick Harrington, discussing the My MPN Voice App

The vlogcast features Dr Patrick Harrington, Consultant Haematologist, Guy’s & St Thomas’ Hospital, discussing the development and progress of an My MPN Voice app designed to help patients monitor their myeloproliferative neoplasm (MPN). ​ The app, launched in April 2024, has over 300 users who track their symptoms and biometric data using a Withings smartwatch.…

MPN AN webinar – the Poiesis trial

MPN Advocates Network invite you to their upcoming webinar in collaboration with Kartos Therapeutics, featuring Dr. Serge Verstovsek, Kartos’ Chief Medical Officer. During this session, Dr. Verstovsek will provide insights into the POIESIS trial, a new and uniquely designed global Phase 3 study for patients with myelofibrosis.  The study will run in 221 hospitals in…